Cargando…
Interleukin-18: A Novel Participant in the Occurrence, Development, and Drug Therapy of Obliterative Bronchiolitis Postlung Transplantation
BACKGROUND: Obliterative bronchiolitis (OB) was a main cause of deterioration of long-term prognosis in lung transplant recipients after the first posttransplant year. Proinflammatory cytokine interleukin-18 (IL-18) strengthened both the natural immunity and acquired immunity and played an important...
Autores principales: | Shu, Ping, Zhang, Wei, Zhang, Yanfei, Zhao, Yanfeng, Li, Yuping, Zhang, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8337162/ https://www.ncbi.nlm.nih.gov/pubmed/34367377 http://dx.doi.org/10.1155/2021/5586312 |
Ejemplares similares
-
Obliterative Bronchiolitis
por: Silva, C. Isabela S., et al.
Publicado: (2008) -
Insight on immune cells in rejection and infection postlung transplant
por: Liao, Mingfeng, et al.
Publicado: (2023) -
Revascularization of the graft in obliterative bronchiolitis after heterotopic tracheal transplantation
por: Nemska, Simona, et al.
Publicado: (2016) -
Activation of Tissue Remodeling Precedes Obliterative Bronchiolitis in Lung Transplant Recipients
por: Ramirez, Allan M., et al.
Publicado: (2008) -
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
por: Suzuki, Hidemi, et al.
Publicado: (2012)